Midazolam 5 mg Injection bulk supplier for pharma manufacturers

Midazolam 5 mg Injection 1 mg/mL, 5 mg/mL Suppliers & Bulk Manufacturers

Available Forms: Intravenous (IV), Intramuscular (IM), and Intranasal Injection

Available Strengths: 1 mg/mL, 5 mg/mL

Reference Brands: Versed(US);

Midazolam is a fast-acting benzodiazepine for sedation, seizures, and anesthesia, available in 1 mg/mL and 5 mg/mL injections and 2 mg/mL oral syrup. Brands include Versed, Buccolam, and Midazolam B. Braun. It is widely sourced via pharma B2B platforms for hospitals, ICUs, and emergency medical services.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Midazolam 5 mg Injection? List it or send an offer →

Product Description:

Midazolam is a short-acting benzodiazepine used for procedural sedation, anesthesia induction, seizures, and ICU sedation. Available in injectable forms (1 mg/mL, 5 mg/mL), oral syrup (2 mg/mL), and buccal/rectal solutions, it is supplied in ampoules, vials, and pre-filled syringes. US brands include Versed and generics. Midazolam’s rapid onset and versatility make it essential in hospitals, ambulatory centers, and emergency care. Pharma B2B platforms regularly supply Midazolam to healthcare institutions through streamlined procurement channels for anesthesia and critical care needs.

Controlled medicine — licensed supply only

This product is controlled in many countries under narcotic, psychotropic, precursor or other drug laws, which vary by country. We supply only licensed buyers holding any import certificate, permit or authorisation their national authority requires, and the Indian manufacturer or exporter must hold the required licences. In India, each export of a narcotic drug or psychotropic substance needs an export authorisation, and export of ephedrine, pseudoephedrine or their preparations a No Objection Certificate, from the Narcotics Commissioner (Central Bureau of Narcotics). We verify permits before quoting.

Midazolam 5 mg Injection — third party manufacturing & bulk supply

Midazolam 5 mg Injection 1 mg/mL, 5 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Midazolam 5 mg Injection is supplied as Intravenous (IV), Intramuscular (IM), and Intranasal Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Midazolam 5 mg Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Midazolam 5 mg Injection →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Midazolam injection is used for sedation, induction of anesthesia, and procedural sedation in adults and pediatric patients. It is commonly administered before surgical or diagnostic procedures to reduce anxiety and produce amnesia. It is also used in intensive care units for continuous sedation and in emergency settings for the management of status epilepticus.

Midazolam injection is made from midazolam hydrochloride, a short-acting benzodiazepine. It works by enhancing the effect of gamma-aminobutyric acid (GABA) in the central nervous system, producing sedative, anxiolytic, muscle-relaxant, and anticonvulsant effects.

The trade names include Versed and Epistatus. Versed is commonly marketed for injectable use, while Epistatus is primarily marketed as an oromucosal (buccal) solution for seizure management in certain regions.

Versed was originally developed and marketed by Roche and is now manufactured or distributed by various pharmaceutical companies depending on the country. Epistatus is marketed by Special Products Ltd in the United Kingdom.

The generic name is midazolam hydrochloride.

Brand names include Versed and Epistatus.

Midazolam injection is manufactured in GMP-certified pharmaceutical facilities in multiple countries including the United States, European Union, and other regions, depending on the marketing authorization holder and supplier. Specific manufacturing sites vary by brand and batch.